Results 251 to 260 of about 145,105 (353)
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
ABSTRACT The immune microenvironment includes immune cells, cytokines, extracellular matrix, vesicles, etc. The interactions between these components form a unique local immune microecology. Although immunity serves as the defense against external pathogens, aberrant immune activation often contributes to disease development.
Guoqing Li+13 more
wiley +1 more source
Exploring protein <i>N</i>-glycosylation in ammonia-oxidizing <i>Nitrososphaerota</i> archaea through glycoproteomic analysis. [PDF]
Nakagawa S+9 more
europepmc +1 more source
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy
ABSTRACT Cerebral tumors, particularly in pediatric patients, pose a significant challenge in oncology. Radiotherapy is a crucial component of the multimodal treatment approach for these tumors. Understanding the molecular basis of these tumors, particularly their response to radiotherapy, is crucial for improving treatment outcomes and patient ...
Ahana Maitra+9 more
wiley +1 more source
Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin‐A can be produced in human kidney 293 cellsbut not in Chinese hamster ovary cells [PDF]
Ingrid M. van den Nieuwenhof+9 more
openalex +1 more source
ABSTRACT Molecular imprinting is a very powerful tool in life science. The research areas benefiting from a wide range of capabilities of molecularly imprinted polymeric nanoparticles (nanoMIPs) include sample preparation, extraction, sensing/detection, diagnostics, and drug delivery.
Milada Vodova+2 more
wiley +1 more source
Folding and Maturation of Tyrosinase-related Protein-1 Are Regulated by the Post-translational Formation of Disulfide Bonds and by N-Glycan Processing [PDF]
Gabriela Negroiu+2 more
openalex +1 more source
Comparative Analysis of Serum N-Glycosylation in Endometriosis and Gynecologic Cancers. [PDF]
Pásztor R+3 more
europepmc +1 more source
A total of 95 ERT‐experienced adults with LOPD were randomized to switch to cipaglucosidase alfa + miglustat or remain on alglucosidase alfa treatment. After 52 weeks, patients remaining on alglucosidase alfa showed worsening or stability for most outcomes, whereas patients who switched to cipaglucosidase alfa + miglustat generally showed stability or ...
Hani Kushlaf+17 more
wiley +1 more source